Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats

Background. YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial i...

Full description

Bibliographic Details
Main Authors: Miaomiao Liu, Yurun Xue, Yingran Liang, Yucong Xue, Xue Han, Ziliang Li, Li Chu
Format: Article
Language:English
Published: Hindawi Limited 2020-01-01
Series:Evidence-Based Complementary and Alternative Medicine
Online Access:http://dx.doi.org/10.1155/2020/8539148
id doaj-7a41d5685925441eae53abb2c47a0212
record_format Article
spelling doaj-7a41d5685925441eae53abb2c47a02122020-11-30T09:11:26ZengHindawi LimitedEvidence-Based Complementary and Alternative Medicine1741-427X1741-42882020-01-01202010.1155/2020/85391488539148Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in RatsMiaomiao Liu0Yurun Xue1Yingran Liang2Yucong Xue3Xue Han4Ziliang Li5Li Chu6School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaSchool of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang 050200, Hebei, ChinaBackground. YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial ischemia (MI) severely reduces myocyte longevity and function. The YangXinDingJi (YXDJ) capsule has been used in the treatment of clinical cardiac disease in China. Nevertheless, the underlying cellular mechanisms for the benefits to heart function resulting from the use of this capsule are still unclear. The aim of this study was to evaluate the protective effects of the YXDJ on isoprenaline-induced MI in rats and to clarify its underlying myocardial protective mechanisms based on L-type calcium channels and myocardial contractility. Materials and Methods. Rats were randomly divided into five groups with ten rats in each group: (1) control; (2) ISO-induced model; (3) high-dose YXDJ (2.8 g/kg/day intraperitoneally for five days), (4) low-dose YXDJ (1.4 g/kg/day for five days); and (5) verapamil (n = 10 in each group). Isoproterenol (ISO) was injected subcutaneously for two consecutive days to induce the rat model of MI. Heart and biochemical parameters were obtained. The patch-clamp technique was used to observe the regulatory effects of YXDJ on the L-type calcium current (ICa-L) in isolated cardiomyocytes. An IonOptix MyoCam detection system was used to observe the contractility of YXDJ on isolated cardiomyocytes. Results. YXDJ caused a significant improvement in pathological heart morphology and alleviated oxidative stress and inflammatory responses. Exposure to YXDJ caused a decrease in blockade of ICa-L in a concentration-dependent manner. Conclusions. The results indicate that YXDJ significantly inhibited inflammatory cytokine expressions, oxidative stress, and L-type Ca2+ channels, and decreased contractility in isolated rat cardiomyocytes. These findings may be relevant to the cardioprotective efficacy of YXDJ.http://dx.doi.org/10.1155/2020/8539148
collection DOAJ
language English
format Article
sources DOAJ
author Miaomiao Liu
Yurun Xue
Yingran Liang
Yucong Xue
Xue Han
Ziliang Li
Li Chu
spellingShingle Miaomiao Liu
Yurun Xue
Yingran Liang
Yucong Xue
Xue Han
Ziliang Li
Li Chu
Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
Evidence-Based Complementary and Alternative Medicine
author_facet Miaomiao Liu
Yurun Xue
Yingran Liang
Yucong Xue
Xue Han
Ziliang Li
Li Chu
author_sort Miaomiao Liu
title Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_short Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_full Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_fullStr Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_full_unstemmed Mechanisms Underlying the Cardioprotection of YangXinDingJi Capsule against Myocardial Ischemia in Rats
title_sort mechanisms underlying the cardioprotection of yangxindingji capsule against myocardial ischemia in rats
publisher Hindawi Limited
series Evidence-Based Complementary and Alternative Medicine
issn 1741-427X
1741-4288
publishDate 2020-01-01
description Background. YangXinDingJi (YXDJ) capsule is one of traditional Chinese medicines (TCMs) derived from Zhigancao decoction, which is usually used for the treatment of cardiovascular disease in China. Aim of the Study. Cardiovascular events are one of the leading causes of death worldwide. Myocardial ischemia (MI) severely reduces myocyte longevity and function. The YangXinDingJi (YXDJ) capsule has been used in the treatment of clinical cardiac disease in China. Nevertheless, the underlying cellular mechanisms for the benefits to heart function resulting from the use of this capsule are still unclear. The aim of this study was to evaluate the protective effects of the YXDJ on isoprenaline-induced MI in rats and to clarify its underlying myocardial protective mechanisms based on L-type calcium channels and myocardial contractility. Materials and Methods. Rats were randomly divided into five groups with ten rats in each group: (1) control; (2) ISO-induced model; (3) high-dose YXDJ (2.8 g/kg/day intraperitoneally for five days), (4) low-dose YXDJ (1.4 g/kg/day for five days); and (5) verapamil (n = 10 in each group). Isoproterenol (ISO) was injected subcutaneously for two consecutive days to induce the rat model of MI. Heart and biochemical parameters were obtained. The patch-clamp technique was used to observe the regulatory effects of YXDJ on the L-type calcium current (ICa-L) in isolated cardiomyocytes. An IonOptix MyoCam detection system was used to observe the contractility of YXDJ on isolated cardiomyocytes. Results. YXDJ caused a significant improvement in pathological heart morphology and alleviated oxidative stress and inflammatory responses. Exposure to YXDJ caused a decrease in blockade of ICa-L in a concentration-dependent manner. Conclusions. The results indicate that YXDJ significantly inhibited inflammatory cytokine expressions, oxidative stress, and L-type Ca2+ channels, and decreased contractility in isolated rat cardiomyocytes. These findings may be relevant to the cardioprotective efficacy of YXDJ.
url http://dx.doi.org/10.1155/2020/8539148
work_keys_str_mv AT miaomiaoliu mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT yurunxue mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT yingranliang mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT yucongxue mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT xuehan mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT ziliangli mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
AT lichu mechanismsunderlyingthecardioprotectionofyangxindingjicapsuleagainstmyocardialischemiainrats
_version_ 1715027926354755584